ArticleFrontiers in neurology2025
The global and regional burden and trends of migraine from 1990 to 2021: Global Burden of Disease Study 2021.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Longitudinal Outcomes of Bilateral and Unilateral Proximal Greater Occipital Nerve Pulsed Radiofrequency in Migraine: A Prospective Randomized Controlled Trial.Medicina (Kaunas, Lithuania) · 2026Trial
- Efficacy and safety of transcutaneous supraorbital nerve stimulation versus topiramate for migraine prevention: a non-inferiority randomized trial.The journal of headache and pain · 2026Trial
- Review
- Oxidative Stress in Migraine-Effect or Cause?Genes · 2026Review
- The Therapeutic Home Environment for Chronic Diseases: A Transdisciplinary Ecosystem for Achieving Migraine Freedom and Managing Comorbid Anxiety, Insomnia, and Chronic Pain.Healthcare (Basel, Switzerland) · 2026Article
- Global, regional, and national burden of upper respiratory infections in adolescents and young adults: an analysis of the Global Burden of Disease Study 2021.Journal of thoracic disease · 2026Article
- Unraveling the Cross-Tissue Neuroimmune-Vascular Genetic Architecture of Migraine Using Integrated Multi-Omics, Single-Cell, and Spatial Transcriptomics: Prioritizing T-Cell Regulatory Networks and Peripheral Targets.International journal of molecular sciences · 2026Article
- The relationship between impulsivity and decision-making styles in individuals with episodic migraine.Frontiers in neurology · 2026Article
- Acupuncture versus Sham Acupuncture for Migraine without Aura: A Systematic Review and Meta-Analysis.Journal of pain research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migraine is a common disabling neurological disorder that affects the quality of human daily life and mental health, potentially leading to disability and imposing a substantial disease burden. There is currently a lack of literature analysis on the global burden and changing trends of migraines. Therefore, this study is of great significance for the development of effective management and prevention strategies for migraine by analyzing the global burden of migraine and its changing trends. Methods: We obtained data on the incidence, prevalence, and disability-adjusted life years (DALYs) of migraine by region and year from the Global Burden of Disease Study 2021 (GBD 2021). The estimated annual percentage change (EAPC) and 95% confidence interval (CI) were used to evaluate the time trend of disease burden, and factors that may affect the EAPC were analyzed. The burden of migraine was analyzed based on the Socio-demographic Index (SDI). Frontier analysis was used to visually demonstrate the burden of development levels in various regions, and the trends of migraine incidence, prevalence, and DALYs over the next decade were predicted. Results: In 2021, the global number of prevalent cases, incident cases, and DALYs for migraine were 1.158 billion, 90.18 million, and 43.38 million, compared with 1990, the percentage changes were 58, 42, and 58%, respectively. In 2021, the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized DALY rate (ASDR) of migraine were the highest in areas with high SDI. Its prevalence, incidence, and DALYs were 15365.1, 1222.5, and 573.6 per 100,000 people. From 1990 to 2021, the ASDR showed an upward trend globally and in all regions, among which ASIR and ASPR in global, China, East Asia, high, high-middle SDI regions were on the rise, while they showed a downward trend in low, low-middle SDI regions. Frontier analysis showed that areas with high SDI generally had greater potential for improvement. We used a predictive model to estimate that ASIR, ASPR, and ASDR of migraine were all on the rise. Conclusion: From 1990 to 2021, the global burden of migraine has increased significantly, especially in middle SDI region. This study highlights the importance of tailored interventions aimed at addressing migraine and thus contributing to the achievement of the Sustainable Development Goals set by the World Health Organization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.